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Abstract
Background: Hypoxic conditions induce the expression of hypoxia-inducible factors
(HIFs) that allow cells to adapt to the changing conditions and alter the expression
of a number of genes including the cystic fibrosis transmembrane conductance
regulator (CFTR). CFTR is a low abundance mRNA in airway epithelial cells even
during normoxic conditions, but during hypoxia its mRNA expression decreases even
further.
Methods: In the current studies, we examined the kinetics of hypoxia-induced
changes in CFTR mRNA and protein levels in two human airway epithelial cell lines,
Calu-3 and 16HBE14o-, and in normal primary bronchial epithelial cells. Our goal was
to examine the posttranscriptional modifications that affected CFTR expression
during hypoxia. We utilized in silico predictive protocols to establish potential
miRNAs that could potentially regulate CFTR message stability and identified miR-
200b as a candidate molecule.
Results: Analysis of each of the epithelial cell types during prolonged hypoxia
revealed that CFTR expression decreased after 12 h during a time when miR-200b
was continuously upregulated. Furthermore, manipulation of the miRNA levels
during normoxia and hypoxia using miR-200b mimics and antagomirs decreased and
increased CFTR mRNA levels, respectively, and thus established that miR-200b
downregulates CFTR message levels during hypoxic conditions.
Conclusion: The data suggest that miR-200b may be a suitable target for
modulating CFTR levels in vivo.
Keywords: CFTR, HIF-1, micro-RNA 200b, hsa-miR-200b-3p
Background
Cystic fibrosis is a lethal monogenic disease caused by mutations in the cystic fibrosis
transmembrane conductance regulator (CFTR) [1]. The CFTR protein is a chloride-
bicarbonate channel that is expressed at low levels in epithelial cells of the airway, and
at higher levels in epithelial cells in the intestine, pancreatic duct and male genital duct
[2]. The post-transcriptional regulation of CFTR expression is controlled, at least in
part, by microRNAs and this type of regulation has been demonstrated in Caco-2 cells,
a human colon carcinoma cell line [3]. Studies by Gillen et al. [3] show that five micro-
RNAs repress endogenous CFTR expression in this cell line, supporting the hypothesis
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that differences in the miRNA profiles in various tissues modulate the expression of
CFTR to different degrees.
In a transcriptomic mRNA and miRNA array-based analysis of the human colonic
epithelial cell line HT29, Guimbellot and colleagues demonstrated that hypoxia mi-
metics treatment decreased CFTR message levels and that a number of miRNAs were
upregulated [4]. Other studies have shown that miRNAs play a role in the posttran-
scriptional regulation of CFTR expression for both the wild-type protein and the most
common mutation in cystic fibrosis, ΔF508 CFTR [5]. miRNAs are endogenous single-
stranded RNAs that regulate the expression of specific genes at the posttranscriptional
level [6, 7]. They regulate gene expression by binding to a specific sequence in the 3′
UTR or sometimes 5′UTR of a target mRNA [8, 9].
Previous studies have shown that some miRNAs are induced during hypoxia and play
a critical role in the cellular adaptive response to low oxygen levels [10]. Using in silico
analysis (miRANDA and TargetScan algorithms) of miRNAs induced during hypoxia,
we identified miR-200b as a potential novel regulator of CFTR mRNA levels. Experi-
mental validation was confirmed in two human epithelial cell lines and in human
primary lung epithelial cells and the results indicate that during hypoxia, miR-200b
decreases CFTR mRNA levels in a time-course dependent manner.
Methods
Cell lines and culture conditions
Calu3 (ATCC® HTB-55™) and HEK293 (ATCC® CRL-1573) cells were obtained from
ATCC. 16HBE14o- cells and HeLaWT were obtained as previously described [11, 12].
Cells were cultured in Minimum Essential modified Eagle’s medium (Invitrogen) with
10% fetal bovine serum in a humidified incubator at 37 °C in 5% CO2 in 6-well plates
and allowed to grow to 70–80% confluence prior to the start of the experiments.
Primary human bronchial epithelial cells (NHBEC) were derived from brushings of
bronchial mucosa obtained during bronchoscopy in normal individuals (i.e., patients re-
ferred for diagnostic bronchoscopy in which chronic airway disease was excluded dur-
ing the further clinical investigation), and aged 30–64 (all donors were current non-
smokers). NHBEC were isolated by enzymatic digestion (pronase and DNAse I, Sigma-
Aldrich, St. Louis, MO), cultured in supplemented bronchial epithelial growth medium
(BEGM; Lonza, Basel, Switzerland) until confluent, and cryopreserved (passage 1) for
further experiments. The sampling protocol was approved by Jagiellonian University
Bioethics Committee, and informed consent was obtained from all participants. For
experiments, thawed primary NHBEC were grown in BEGM medium (Lonza), as an
adherent cell line, and maintained in culture until passage 5. Cells were seeded into 6-
well plates or 2 cm dishes and allowed to grow to 70–80% confluence prior to the start
of the experiments.
Induction of hypoxia
Hypoxia was induced in a CO2/O2 incubator/chamber for hypoxia research (Invivo2,
Baker Ruskin). Briefly, cells were cultured in 2 cm dishes at 0.9% O2 for the time
periods specified. Control cells were maintained in normoxic conditions in the same
incubator and harvested at the specified times.
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Isolation of RNA and microRNA
Total RNA containing the microRNA fraction was isolated using the miRNeasy kit
(Qiagen). RNA concentrations were calculated based on the absorbance at 260 nm.
RNA samples were stored at −70 °C until use.
5′UTR and 3′UTR CFTR Luciferase reporter assays
A human 5′UTR CFTR promoter-driven firefly luciferase reporter construct (pCFTR-pLuc)
was purchased from Panomics (Cat. #: LR1020, Panomics Inc., Fremont, CA). This con-
struct contains a 1000-bp fragment of the human CFTR 5′-UTR upstream of firefly lucifer-
ase as described in [13]. A human 3′UTR CFTR firefly luciferase reporter construct was
purchased from GeneCopoeia (HmiT000948-MT06 - miRNA 3′UTR target expression
clone for NM_000492.3) along with the control vector (CmiT000001-MT06 (miRNATarget
clone control vector for pEZX-MT06).
To test the transcriptional and post-transcriptional activity of the human CFTR UTR
regions, Calu3 cells and HEK293 were transfected with the constructs described above
or with control plasmids provided by Panomics/GeneCopoeia. Twenty-four hours be-
fore experiments, cells were seeded onto 6-well plates at ∼40% confluency and trans-
fected using Lipofectamine 2000 (Invitrogen). For the specified experiments, miR-200b
and miR-200c analogs were cotransfected. Each well received 2 μg of total plasmid
DNA and 1 μg of a vector of interest plus 1 μg of Renilla luciferase as an internal con-
trol for the 5′UTR or 3′UTR constructs. For the 5′UTR and 3′UTR cotransfections
(2 μg total), 1 μg of each reporter vector was used as well as 1 μg of Renilla luciferase
as an internal control. miR-200b mimic was used at final concentration of 10 nM. At
the time points indicated, cells were lysed using luciferase assay lysis buffer (Promega)
and firefly/Renilla luciferase activities were measured using the Dual-Luciferase Re-
porter Assay (Promega) according to the manufacturer’s protocol. Results in treated
cells were plotted as the percent decrease in arbitrary light units compared with control
cells.
Measurement of mRNA and miRNA levels using quantitative Real Time PCR (qRT-PCR)
We used TaqManOne-Step RT-PCR Master MixReagents (Applied Biosystems) as de-
scribed previously [14, 15] using the manufacturer’s protocol. The relative expressions
were calculated using the comparative relative standard curve method [16]. We used 18S
rRNA as the relative control for our studies. We also validated this relative control against
another housekeeping gene, TATA-binding protein (TBP). As relative controls for miRNA
quantification, we validated and used RNU48. TaqMan probes ids used were: CFTR -
Hs00357011_m1; 18S - Hs99999901_s1; TBP - Hs4332659_m1; RNU48 – 001006; miR-
200b – 002251; miR-200c - 002300.
miRNA analog transfections
miR-200b mimic (id MC10492) and antagomiR (id MH10492), as well as miR-200c
mimic (id MC11714) and antagomiR (id MH11714), were purchased from Ambion.
Cells were transfected using the Lipofectamine RNAiMax according to manufacturer’s
protocol. miR-200b/c mimics and antagomiRs were used at final concentrations of
10 nM and 20 nM, respectively. The transfected cells were cultured for 2 days prior to
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further analysis. The degree of miRNA over-expression or knockdown was determined
by qRT-PCR (Additional file 1: Figure S1B). cel-miR-67 was used as a control
(Ambion assay id MC22484). As additional controls, Ambion siRNA Negative
Control 1 (no. 4390843), Ambion mimic control (no. 4464060) and Ambion
antagomiR control (no. 4464076) were used as well.
Western blots
Cells were lysed in RIPA buffer (150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate,
0.1% SDS, 50 mM Tris- HCl, pH 8.0) supplemented with protease Inhibitor Complete
Mini (Roche) on ice for 15 min. The cell lysates were rotated at 4 °C for 30 min and
the insoluble material was removed by centrifugation at 15,000 g for 15 min. Protein
concentrations were determined by BioRad™ Protein Assay using bovine serum albumin
(BSA) as a standard. Following the normalization of protein concentrations, lysates
were mixed with an equal volume of 2X Laemmli sample buffer and incubated for
5 min at 95 °C prior to separation by SDS PAGE on stain-free TGX gradient gels
(BioRad). Following SDS-PAGE, the proteins were transferred to polyvinylidene fluor-
ide membranes (300 mA for 90 min at 4 °C). The membranes were then blocked with
BSA (Sigma-Aldrich) dissolved in PBS/Tween-20 (3% BSA, 0.5% Tween-20 for 1–2 h),
followed by immunoblotting with the primary antibody specified for each experiment
CFTR (Merck MM13–4 diluted at 1:1000), HIF-1α (Abcam ab16066, diluted at 1:1000);
and beta ACTIN (Abcam ab1801, diluted at 1:1000). After the washing steps, the mem-
branes were incubated with goat anti-rabbit IgG (H + L chains) or with goat anti-mouse
IgG (H + L) HRP-conjugated secondary antibodies (BioRad) and detected using ECL
(Amresco). Densitometry was performed using Image Lab software v. 4.1 (BioRad).
Statistical analysis
The results were expressed as the mean ± standard deviation (SD). Statistical signifi-
cance among means was determined using the Student’s t-test (two samples, paired
and unpaired) [17]. Analyzes were performed with Dell Statistica version 13 (Dell Inc.,
2016).
Results
Downregulation of CFTR during hypoxia involves post-transcriptional HIF-1-dependent
mechanisms
Previous studies reported that CFTR protein and mRNA levels were reduced during
hypoxia in human lung epithelial cells [18, 19]. However, these reports were limited to
chemical hypoxia induction and a single time point of physiological hypoxia and there-
fore did not provide the information about the dynamics of hypoxic CFTR message
downregulation. Hence, to examine the kinetics of hypoxia-induced changes of CFTR
protein and mRNA levels, we performed time-course studies during physiological hyp-
oxia in two lung epithelial cell lines, Calu3 cells (epithelial lung adenocarcinoma; de-
rived from metastatic site: pleural effusion) and 16HBE14o- cells (SV40-immortalized
human bronchial epithelial cells). Both Calu3 and 16HBE14o- cell lines are commonly
used in vitro for studying CFTR biogenesis and function. As shown in Fig. 1a, the
changes in CFTR mRNA profiles show a significant decrease in mRNA after 8 h in
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both cell lines and correlate well with the CFTR protein changes (Fig. 1b). During the
early stages of hypoxia up to 8 h, CFTR protein levels remain either mostly unchanged
(Calu3 cells) or slightly induced (16HBE14o- cells), whereas, under chronic hypoxia
(after 12 h), CFTR levels are significantly reduced and drop below half of the normoxic
levels in both cell lines.
In a previous study, Zheng and coworkers reported that HIF-1 is responsible for
decreases in CFTR mRNA and protein [18], and therefore we followed the levels HIF1A
message and HIF-1α protein during the hypoxia time course as well (Fig. 1a, b). In both
Calu3 and 16HBE14o- cells, the maximum of HIF-1α protein increases during hypoxia
immediately preceded the decline in CFTR protein and mRNA, which is consistent
with previous studies in intestinal epithelia that HIF-1 decreases CFTR mRNA levels
b
a
Fig. 1 Regulation of CFTR during hypoxia in human lung epithelial cells, Calu3 cells (left panels) and
16HBE14o- cells (right panels). a CFTR mRNA is reduced during hypoxia. CFTR mRNA levels were monitored
in qRT-PCR experiments. The results from 3 independent experiments (n = 12) are plotted normalized to
18S rRNA levels and expressed as a fold-change over the normoxic control. b Hypoxia sequentially increases
HIF-1α protein levels and reduces CFTR protein levels. Protein expression levels of were monitored with
SDS-PAGE and Western Blot and normalized to β-actin levels. Two individual samples (4 μg of total protein
per lane) were tested for each time point and the experiments were repeated twice. Error bars represent
standard deviations. Significant changes (P < 0.05) are marked with an asterisk
Bartoszewska et al. Cellular & Molecular Biology Letters  (2017) 22:23 Page 5 of 14
during hypoxia. To test this hypothesis using another approach, we utilized hypoxia
mimetics (CoCl2 and dimethyloxalylglycine (DMOG)) that stabilize the HIF-1α protein
and thus induce HIF-1 transcriptional activity [20]. We analyzed the related changes in
CFTR mRNA in Calu3 and 16HBE14o- cells as well as in a HeLa cell line that
expresses recombinant CFTR mRNA (HeLaWT) that does not contain the 5′ or 3′
UTRs of CFTR (Fig. 2a). The chemically stabilized HIF-1 activity mediated by the hyp-
oxia mimetics decreased CFTR mRNA in both Calu3 and16HBE14o- cells, whereas it
had no effect on exogenous CFTR mRNA levels in HeLaWT cells.
While these data confirm that during hypoxia, CFTR mRNA is decreased, they
do not address whether this is a transcriptional and/or post-transcriptional HIF-1-
dependent mechanism. Since we did not observe a clear negative correlation
between CFTR mRNA and HIF-1α expression profiles (Fig. 1), this suggested the
possibility that other HIF-1-dependent secondary post-transcriptional factors might
be responsible for the decline in CFTR message and protein expression. To
examine this hypothesis, we tested the function of the CFTR 5′UTR and 3′UTR
mRNAs during hypoxia using specific luciferase reporters. As shown in Fig. 2b, the
hypoxia mimetics CoCl2 and DMOG reduced both 5′ UTR- and 3′UTR-dependent
luciferase expression, suggesting that both untranslated regions of CFTR mRNA
are involved in HIF-1-dependent reduction of CFTR mRNA. Interestingly, luciferase
a
b
Fig. 2 Downregulation of CFTR expression during hypoxia is HIF-1 dependent and relies on both the 5′ and
3′ UTRs of CFTR mRNA. a Calu3, 16HBE14o- and HeLa WT CFTR cells were treated with hypoxia mimetics
(500 μM DMOG for 12 h (light grey) and 200 μM CoCl2 for 12 h (dark grey)) and the mRNA levels were
monitored in qRT-PCR experiments. CFTR mRNA levels from 2 independent experiments (n = 8) are plotted
relative to 18S rRNA levels and expressed as a fold change over the untreated control. b Calu3 cells were
transfected with 5′UTR CFTR luciferase reporter (white), 3′UTR CFTR luciferase reporter (light grey) and co-
transfected with both 5′UTR and 3′UTR CFTR luciferase reporters (dark grey) and treated with hypoxia
mimetics (500 μM DMOG or 200 μM CoCl2 for 12 h) and the luciferase activity was monitored. These
reporters were normalized to internal controls (Renilla) firefly luciferase activities from 2 independent
experiments (n = 6) and plotted and expressed as a fold-change over non-treated control. Error bars
represent standard deviations. Significant changes (P < 0.05) are marked with an asterisk
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expression from the CFTR 3′UTR reporter construct was more inhibited than the
5′UTR reporter, and that the two effects were additive. This suggested a synergistic
effect of both UTRs in reducing CFTR mRNA during hypoxia and the involvement
of both the 5′UTR and 3′UTR in transcriptional/post-transcriptional HIF-1-
dependent mechanisms.
miR-200b is induced by hypoxia in a HIF-1-dependent manner in human lung
epithelial cells
The expression of many miRNAs has been shown to be HIF-1 dependent under hyp-
oxia [21]. To test the hypothesis that such a HIF-1-dependent miRNA could contribute
to CFTR downregulation, we analyzed the CFTR 3′UTR sequence for potential binding
sites using the miRANDA and TargetScan algorithms [22, 23]. Using this approach, we
a
b
Fig. 3 Hypoxia induces miR-200b in human airway epithelial cells in a HIF-1-dependent manner. a The
predicted target site of miR-200b in CFTR 3′UTR is shown above. The miR-200b target site was predicted in
human CFTR 3′UTR only, Hypoxia-induced changes in the expression profiles of miR-200b and miR-200c in
Calu3 and 16HBE14o- cells are shown. The miRNA levels were monitored in qRT-PCR experiments. The
results from 2 independent experiments (n = 8) are plotted normalized to RNU48 and expressed as a
fold-change over the normoxic control. b Calu3 and 16HBE14o- cells were treated with hypoxia mimetic
(200 μM CoCl2 for 12 h) and the miRNA levels were monitored in qRT-PCR experiments. miR-200b and
miR-200c levels were measured in 3 independent experiments (n = 10) and are plotted relative to RNU44
levels and expressed as a fold change over the untreated controls. Error bars represent standard deviations
(SD). Significant changes (P < 0.05) are marked with an asterisk
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identified a potential target site for miR-200b/200c at position 529 bases from the stop
codon in the 3′UTR of CFTR mRNA (Fig. 3). Since the expression of miR-200b and
miR-200c was previously reported to be hypoxia-dependent in human endothelial cells,
we tested their expression profiles during hypoxia in the Calu3 and 16HBE14o- cells.
As shown in Fig. 3a, miR-200b was induced up to 2-fold during the hypoxia time
course in both cell lines, whereas miR-200c was not elevated and therefore probably
not involved in CFTR regulation during hypoxia. The miR-200b levels were elevated to
a maximum level at 4 h and that correlated well with HIF-1’s maximal expression, and
importantly, miR-200b levels remained elevated throughout the 24-h test period.
Furthermore, the increase in miR-200b levels correlated negatively with the respective
decrease in CFTR mRNA and protein, and supported miR-200b’s role in regulating
CFTR expression.
Although in our previous studies in human primary endothelial cells (HUVECs), we
identified a HIF response element (HRE) consensus in the proximity of miR-200b
sequence, the hypoxia mimetics had limited impact on miR-200b’s expression [24].
However, miRNA expression, as well as HIF-1 activity, is often tissue-specific, and
therefore we tested whether the induction of HIF-1 activity would affect miR-200b ex-
pression in lung epithelial cells. As shown in Fig. 3b, CoCl2 induced HIF-1 activity and
resulted in the elevation of miR-200b levels in both Calu3 and 16HBE14o- cells, sug-
gesting that hypoxic induction of this miRNA is HIF-1 dependent. Furthermore, CoCl2
treatment had no significant effect on miR-200c expression.
miR-200b binds to CFTR’s 3′UTR
Although the miRNAs recognize specific target sequences, these sequences (6–8 nt)
can be present in the 3′UTRs of many different genes. Hence, in order to exclude in-
direct effects of miR-200b on CFTR expression, we utilized 3′UTR luciferase reporter.
Briefly, a plasmid containing the 3′ UTR of human CFTR gene was tested in a lucifer-
ase gene construct that was co-expressed in human embryonic kidney cells 293
(HEK293) in the presence and absence of a miR-200b analog (mimic). HEK293 cells
were used since they express very low endogenous levels of miR-200b/c. As shown in
Fig. 4a, miR-200b overexpression resulted in significantly reduced luciferase expression
compared to the no treatment control. Furthermore, a similar experiment with
miR-200c that has only one base difference in seed sequence from miR-200b did
not result in a luciferase signal reduction (Fig. 4b), confirming the direct inter-
action between miR-200b and its target site at 3′UTR of CFTR mRNA.
Next, we tested the effects of miR-200b overexpression and inhibition on CFTR
mRNA levels after 12 h of hypoxia. The miR-200b upregulation with mimic reduced
CFTR mRNA in hypoxia and normoxia in both Calu3 and 16HBE14o- (Fig. 5a). Fur-
thermore, the inhibition of miR-200b activity with antagomiR increased CFTR mRNA
in both cell lines (Fig. 5a). In parallel, we followed miR-200b analogs effect on CFTR
protein levels. As shown in Fig. 5b, in normoxia and during hypoxia, miR-200b overex-
pression resulted in the reduction of CFTR protein levels in 16HBE14o- cells. Whereas
in Calu3 cells, mimic only had an effect during normoxia, although both cell lines had
elevated CFTR protein with the antagomir treatment during hypoxia, confirming the
physiological effect of miR-200b CFTR expression during low oxygen levels.
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Given that miRNA levels and function in cancer cell lines often differs from primary
cells, we examined miR-200b’s impact on CFTR expression in primary human lung
cells (NHBEC Normal Human Bronchial Epithelial Cells) obtained from 3 donors. As
shown in Fig. 6a, miR-200b was significantly induced ~2.5-fold during hypoxia in
NHBECs, while the CFTR mRNA reduced by about 50% during normoxia (P = 0.07)
and less so during hypoxia (Fig. 6b). However, the smaller effect during hypoxia may be
due to already very low CFTR mRNA basal levels in NHBECs (approximately 50 fold
lower than in immortalized cells, Additional file 1: Figure S1A). Inhibition of miR-200b
by antagomiR, however, significantly increased CFTR mRNA levels in both conditions
(Fig. 6b), confirming the physiological relevance of results obtained in immortalized cell
lines. Importantly, we were able to observe a significance decrease in CFTR protein
levels with miR-200b overexpression during normoxia, and a decrease during hypoxia,
though it was not significant (P = 0.08) in NHBECs (Fig. 6c). miR-200b antagomiR
treatment resulted in a significant increase in CFTR protein levels during both
normoxia and hypoxia and this supported by the changes in CFTR mRNA as well. Im-
portantly, our results obtained in primary human lung cells confirmed that miR-200b
regulates CFTR expression.
Discussion
The regulation of CFTR expression appears to be tissue specific and understanding its
regulation is important in potential therapies for cystic fibrosis (CF) given that many of
the disease causing mutations result in lower expression of this critically vital gene.
Transcriptional regulation of CFTR is complex and includes elements within the
a
b
Fig. 4 miR-200b binds to the predicted target sequence in the CFTR 3′UTR. a HEK293 cells were transfected
with 3′UTR CFTR luciferase reporter construct alone (white) or together with miR-200b mimic (grey, left
panel) or miR-200c mimic (grey, right panel). Similar experiments were performed on control vector that
did not contain the miR-200b/miR-200c target site (not shown). Data were normalized to control Renilla lu-
ciferase activities from 2 independent experiments (n = 6) and are expressed as a fold-change over
control. Error bars represent standard deviations (SD). Significant changes (P < 0.05) are marked with an as-
terisk. b The comparison of miR-200b and miR-200c seed sequences is shown
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promoter and intronic enhancers (reviewed in [25]). It has also been established that
miRNA networks regulate CFTR expression as well [5, 26].
Although the role of miRNAs in posttranscriptional gene regulation is clearly
established, it is now becoming evident that recent studies have shown that specific
alterations in miRNA expression occur in cystic fibrosis (reviewed in [27]). Moreover,
differences in miRNA expression are also present in chronic obstructive pulmonary
disease, asthma, lung inflammation, and in smoke exposure in humans [28], suggesting
that miRNA network changes can potentially influence disease pathogenesis. For CF,
this is illustrated for the ΔF508 CFTR mutation, the most common mutation in CF, by
studies that show that there is increased expression of miR-145, miR-223, and miR-494
a
b
Fig. 5 miR-200b decreases the expression of CFTR mRNA during normoxia and hypoxia. a Calu3 and
16HBE14o- cells were transfected with miR-200b mimic or antagomir and the mRNA levels were monitored
in qRT-PCR experiments in normoxic conditions and after 12 h of hypoxia. CFTR mRNA levels from 2 independent
experiments (n = 8) are normalized to 18S rRNA levels and expressed as a fold change over the transfection
control. b The corresponding changes in CFTR protein levels of were detected with SDS-PAGE and Western Blot
analyses and normalized to the β-actin levels. Two individual samples (3 μg of total protein per lane) were tested
for each treatment and the experiments were repeated twice. Error bars represent standard deviations (SD). Sig-
nificant changes (P< 0.05) are marked with an asterisk
Bartoszewska et al. Cellular & Molecular Biology Letters  (2017) 22:23 Page 10 of 14
in vivo in the bronchial epithelium of ΔF508 patients and this correlated with de-
creased CFTR expression [25, 29]. Furthermore, the introduction of a miRNA site
through a mutation has been shown to increase the affinity of a miRNA that in vitro
lowers the expression of the CFTR protein [30].
Using transcriptomic mRNA and miRNA-array-based experiments in colonic
epithelial cells, Guimbellot and colleagues demonstrated that a number of genes were
up- or down-regulated during hypoxia and CFTR was one of those genes that was
downregulated [4]. It has also been reported that HIF-1 expression decreases CFTR ex-
pression in intestinal epithelium [18], suggesting that transcriptional regulation controls
CFTR repression during hypoxia. The goal of the present study was to determine the rela-
tive contribution of miRNA-mediated post-transcriptional mechanisms as well.
a
c
b
Fig. 6 miR-200b decreases the expression of CFTR mRNA during normoxia and hypoxia in primary normal
human bronchial epithelial cells (NHBEC). a The levels of miR-200b after 12 h of hypoxia in NHBECs from 3
independent experiments (n = 6) are plotted normalized to RNU44 levels and expressed as a fold change
over the normoxia control. b NHBEC cells were transfected with miR-200b mimic or antagomir and the
mRNA levels were monitored in qRT-PCR experiments in normoxic conditions and after 12 h of hypoxia.
CFTR mRNA levels from 2 independent experiments (n = 8) are plotted normalized to 18S rRNA levels and
expressed as a fold change over the transfection control. c The corresponding changes of CFTR protein levels
were monitored with SDS-PAGE and Western Blot analysis and normalized to the β-actin levels. Two individual
samples (3 μg of total protein per lane) were tested for each treatment and the experiments were repeated
twice. Error bars represent standard deviations (SD). Significant changes (P < 0.05) are marked with an asterisk
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Our in silico predictions indicated that miR-200b and miR-200c were putative
candidates for CFTR posttranscriptional regulation. Using a hypoxia time course, we
show that CFTR mRNA expression decreased after 8 h in both human airway epithelial
cell lines, whereas HIF-1α protein expression was elevated as early as 2 h. Interestingly,
the CFTR protein levels were not dramatically lower until 12 h, suggesting that more
than just HIF-1 suppression of CFTR expression was occurring. To test for potential
miRNA effects on CFTR expression, we utilized luciferase reporter constructs contain-
ing either the human CFTR 5′UTR, the 3′UTR or both and, in conjunction with
chemical mimics of hypoxia that stabilized HIF-1 protein expression. We found
that the 3′UTR was the more important region for suppression of expression, but
that both regions were important and additive in their effects.
To differentiate between miR-200b and miR-200c, we found that miR-200b was
elevated in both cell lines during hypoxia, whereas miR-200c was not. Furthermore,
in Guimbellot et al.’s analysis of HT29 colonic epithelial cells, they identified 28
miRNAs that were upregulated during hypoxia, and miR-200b was one of them
[4]. This suggested that miR-200b could have effects on CFTR mRNAs in more
than just airway epithelia. Using the 3′UTR CFTR luciferase constructs we also
demonstrated that miR-200b had a direct effect on luciferase expression, and this
clearly established a direct effect on CFTR message levels. Final support for the
role of miR-200b comes from the negative and positive effects of miR-200b mimics
and antagomirs on CFTR expression changes, including the results in the primary
airway cells. Taken together, the results suggest that during low oxygen conditions
which could occur in various lung pathologies, miR-200b is upregulated and has a
direct inhibitory effect on CFTR message and protein expression in human airway
epithelial cells.
Conclusions
In summary, our studies suggest that the HIF-1 dependent physiological changes in
miR-200b levels in human airway epithelia under hypoxia contribute directly to CFTR
downregulation during hypoxia. Hence, this results complement previous studies
Fig. 7 Model for negative regulation of CFTR expression during hypoxia by HIF-1 and miR-200b. During
hypoxia, HIF-1 activity is induced and HIF-1 binds to the hypoxia response element (HRE) sequence located
in CFTR 5′UTR and has been reported to decrease CFTR expression (Zheng et al. [18]). Our studies show that
HIF-1 induces miR-200b expression and binds to the target sequence (TS miR-200b) located at the 3′UTR of
CFTR mRNA, which further decreases CFTR mRNA and protein expression
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indicating HIF-1’s direct transcriptional effects on downregulation of CFTR with an
additive post-transcriptional mechanism that involves a hypoxia-induced miRNA
(Fig. 7). Furthermore, stabilization of CFTR protein levels during hypoxia through
inhibition of miR-200b’s actions may provide a novel therapeutic opportunity for
increasing CFTR expressions levels during various lung pathologies.
Additional file
Additional file 1: Figure S1. Endogenous levels of miR-200b in NHBEC, Calu3 and 16HBE14o- cells. (A) Comparison
of CFTR mRNA (white) and miR-200b (grey) relative levels between NHBEC (primary cells), Calu3 and 16HBE14o- cells
during normoxic conditions. CFTRmRNA levels from 2 independent experiments (n = 8) are plotted normalized to 18S
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and 16HBE14o- cells were transfected with miR-200b antagomir (left) or mimic (right) and the miRNA levels were
monitored in qRT-PCR experiments. miR-200b levels from 2 independent experiments (n = 8) are plotted normalized to
RNU48 levels and expressed as a fold change over the transfection control. Error bars represent standard deviations
(SD). Significant changes (P < 0.05) are marked with an asterisk. (PDF 348 kb)
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